According to the Wall Street Journal, the Trump administration is in talks with Eli Lilly and Novo Nordisk to offer weight-loss drugs at discounted prices through TrumpRx, a direct-to-consumer prescription drug platform.
2025-11-05
According to the Wall Street Journal, the Trump administration is in talks with Eli Lilly and Novo Nordisk to offer weight-loss drugs at discounted prices through TrumpRx, a direct-to-consumer prescription drug platform.